NOS1AP and central nervous system cancer: In glioma C6 cells, the CCK8 assay showed that silencing CAPON by shRNA significantly increased the cell viability at 24 h (p < 0.001), 48 h (p = 0.001) and 72 h (p = 0.001) (Figure 3A).